This case emphasizes the need for regular pulmonary screening in all JDM patients, regardless of their antibody profile, and suggests that our understanding of the protective role of TIF1-γ against pulmonary fibrosis requires further investigation. The gene discussed is TRIM33; the disease is pulmonary fibrosis.